Concomitant Use of VA-ECMO and Impella Support for Cardiogenic Shock

BACKGROUND: VA-ECMO with concomitant Impella support (ECpella) is an emerging treatment modality for cardiogenic shock (CS). Survival outcomes by CS etiology with ECpella support have not been well-described. METHODS: This study was a retrospective, single-center analysis of patients with cardiogeni...

Descripción completa

Detalles Bibliográficos
Autores principales: Modi, Shan P., Hong, Yeahwa, Sicke, McKenzie M., Hess, Nicholas R., Klass, Wyatt J., Ziegler, Luke A., Rivosecchi, Ryan M., Hickey, Gavin W., Kaczorowski, David J., Ramanan, Raj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402237/
https://www.ncbi.nlm.nih.gov/pubmed/37546750
http://dx.doi.org/10.1101/2023.07.24.23293127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402237/
https://www.ncbi.nlm.nih.gov/pubmed/37546750
http://dx.doi.org/10.1101/2023.07.24.23293127

Ejemplares similares